Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: Implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

George L. Melikian, Soo Yon Rhee, Vici Varghese, Danielle Porter, Kirsten White, Jonathan Taylor, William Towner, Paolo Troia-Cancio, Jeffrey Burack, Edwin DeJesus, Gregory K. Robbins, Kristin Razzeca, Ron Kagan, Tommy F. Liu, W. Jeffrey Fessel, Dennis Israelski, Robert W. Shafer

    Research output: Contribution to journalArticlepeer-review

    59 Scopus citations

    Fingerprint

    Dive into the research topics of 'Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: Implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing'. Together they form a unique fingerprint.

    Medicine & Life Sciences